Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: UC47AV3PU8

Pharmacology

Action Mechanism of Action Reference
BINDING AGENT CD22 binding agent PubMed FDA PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 D054198 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297558
FDA SRS UC47AV3PU8